Seller record · Telehealth service

Eviora MD

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The program pages, the footer and the terms refer only to partner compounding pharmacies and state-licensed compounding pharmacies. 1 more criterion also fails; see the table below.

At a glance

Eviora MDTelehealth service

6/8criteria passed
Price
Semaglutide from $149 a month, tirzepatide from $169
Sells
semaglutide injection, tirzepatide injection, GLP-1 microdose, and 5 more
FDA letters
None on file
Visit Eviora MDSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A cash-pay telehealth platform offering compounded GLP-1 programs, namely semaglutide and tirzepatide injections, a lower-dose microdose protocol and a daily oral option, and peptide therapies including tesamorelin, sermorelin, PT-141 and NAD+. Monthly starting prices are printed, and no dispensing pharmacy is named.

Operating entity EVIORA LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSEviora MD's semaglutide product page; Eviora MD's website
S2Prescription gatingPASSEviora MD's eligibility page; Eviora MD's website
S3Pharmacy identificationFAILEviora MD's semaglutide product page; Eviora MD's terms
S4Compounding disclosurePASSEviora MD's peptides page; Eviora MD's website
S5Analytical documentationFAILEviora MD's peptides page; Eviora MD's terms
S6Business addressPASSEviora MD's contact page; Eviora MD's privacy page; Eviora MD's terms
S7Price disclosurePASSEviora MD's peptides page; Eviora MD's website
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews and authorizes every consultation, and treatment moves forward only when the provider decides it is appropriate; the footer says every prescription decision is made by an independent licensed practitioner.Source: Eviora MD's semaglutide product page; Eviora MD's website.
S2PASSThe eligibility button opens an assessment whose first screen asks what the buyer would like support with, and the home page says the charge is $0 for a buyer who is not approved.Source: Eviora MD's eligibility page; Eviora MD's website.
S3FAILNo filling pharmacy is named. The program pages, the footer and the terms refer only to partner compounding pharmacies and state-licensed compounding pharmacies.Source: Eviora MD's semaglutide product page; Eviora MD's terms.
S4PASSThe disclaimer at the foot of every page and the note beneath the peptides price list state that compounded medications are not FDA-approved, and the home page adds that compounded semaglutide and tirzepatide are not the same as the branded medications.Source: Eviora MD's peptides page; Eviora MD's website.
S5FAILNo certificate of analysis or lot document is published on the program pages, the peptide pages, the terms, the privacy policy or the HIPAA notice.Source: Eviora MD's peptides page; Eviora MD's terms.
S6PASSEVIORA LLC at 2807 N Parham Rd, Ste 320 #7683, Henrico, VA 23294, printed as the clinic address on the contact page and as the mailing address in the privacy policy. The terms name Delaware law.Source: Eviora MD's contact page; Eviora MD's privacy page; Eviora MD's terms.
S7PASSThe semaglutide injection from $149 a month, the tirzepatide injection from $169, the GLP-1 microdose from $199 and the oral GLP-1 from $229 a month. Tesamorelin from $299, sermorelin and PT-141 from $249 and NAD+ from $199 a month. The home page banner presents GLP-1 weight loss from $149 a month as a new patient offer, and the program pages print no figure.Source: Eviora MD's peptides page; Eviora MD's website.
S8PASSNo FDA warning letter names Eviora MD or EVIORA LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide injection, tirzepatide injection, GLP-1 microdose, GLP-1 oral, tesamorelin, sermorelin, NAD+, PT-141.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells PT-141Who sells tesamorelin

Visit Eviora MD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.